There is increasing evidence that cocaine-and amphetamine-regulated transcript (CART) peptide is abundantly expressed in the anterior pituitary of birds and mammals, suggesting that CART peptide may be a novel pituitary hormone and its expression and secretion is likely controlled by the hypothalamic factor(s). To substantiate this hypothesis, using chicken as an animal model, we examined the effects of gonadotropin-releasing hormone (GnRH) on pituitary CART secretion and expression and investigated whether GnRH could modulate plasma CART levels. The results showed that: (1) chicken GnRH (GnRH1 and GnRH2) could potently stimulate CART peptide secretion in intact pituitaries incubated in vitro, as detected by Western blot; (2) GnRH could also stimulate CART mRNA expression in cultured pituitary cells, as revealed by quantitative real-time polymerase chain reaction (qPCR) assay; (3) GnRH actions on pituitary CART expression and secretion are likely mediated by GnRH receptor coupled to the intracellular Ca 2+ , MEK/ERK, and cAMP/PKA signaling pathways; and (4) plasma CART levels are high in chickens at various developmental stages (1.2-3.5 ng/ml) and show an increasing trend towards sexual maturity, as detected by enzyme-linked immunosorbent assay (ELISA). Moreover, plasma CART levels could be significantly induced by intraperitoneal administration of GnRH in chicks. Taken together, our data provide the first collective evidence that CART peptide is a novel pituitary hormone and its expression and secretion are tightly controlled by hypothalamic GnRH, thus likely being an active player in the hypothalamic-pituitary-gonadal (HPG) axis.
INTRODUCTION
It is well documented that cocaine-and amphetamine-regulated transcript (CART), an anorectic peptide of 41-or 48-amino acids with three intra-molecular disulfide bonds, plays an important role in the regulation of feeding and energy balance in mammals (Rogge et al., 2008) . CART peptide encoded by CART gene was first discovered in abundance in the rat hypothalamus, in which it may act as a downstream effector of leptin with potent appetite-suppressing activity (Douglass et al., 1995; Gautvik et al., 1996; Kristensen et al., 1998; Elias et al., 2001) . Besides the hypothalamus, CART is also expressed in other brain regions, the peripheral nervous system (PNS) and peripheral tissues of mammals including the anterior pituitary, ovary, and pancreas (Koylu et al., 1997; Jensen et al., 1999; Thim et al., 1999; Murphy et al., 2000; Kobayashi et al., 2004; Wierup et al., 2006; Ma et al., 2016) , and is suggested to be involved in the regulation of many other physiological processes, such as drug reward and reinforcement, stress, pancreatic secretion, bone remodeling, and ovarian follicle development and steroidogenesis (Kobayashi et al., 2004; Elefteriou et al., 2005; Sen et al., 2007; Rogge et al., 2008; Abels et al., 2016) .
Besides being a local regulatory factor found in the central nervous system (CNS) and peripheral tissues, CART peptide is present in the blood at physiological levels in mammals. In humans, the levels of plasma CART were reported to be higher in patients with neuroendocrine malignancy (Bech et al., 2008) . In rats and rhesus macaques, the levels of circulating CART display diurnal variations, which is partially influenced by the circulating corticosteroids (Stanley et al., 2004; Vicentic et al., 2004) . Moreover, blood CART levels are also related to the energy balance status, such as pregnancy/lactation in rats (Vicentic et al., 2004; Smith et al., 2006; Vicentic, 2006) . Despite the detection of physiological level of circulating CART in various species, its source has remained controversial. Several studies have suggested that the anterior pituitary may be a source of circulating CART peptide in mammals (Stanley et al., 2004) . In rodents, CART mRNA and protein are found in the anterior pituitary Murphy et al., 2000) . More recent studies revealed that CART may be expressed in the gonadotrophs, lactotrophs, corticotrophs, thyrotrophs, and/ or somatotrophs in rodents (Kuriyama et al., 2004; Stanley et al., 2004; Kappeler et al., 2006; Mortensen and Camper, 2016) . In addition, pituitary CART secretion is reported to be under the control of hypothalamic factors such as corticotropin-releasing hormone (CRH) and circulating corticosterone (Stanley et al., 2004; Vicentic et al., 2004; Kappeler et al., 2006) . Furthermore, intraperitoneal administration of CRH is demonstrated to increase plasma CART levels in rats (Stanley et al., 2004) . Taken together, these findings tend to support the idea that CART is a pituitary hormone, which is released into the circulation under the influence of hypothalamic factor(s) and peripheral signal (Stanley et al., 2004; Kappeler et al., 2006) . Regrettably, this notion has received little attention till now.
Recently, we have identified chicken CART gene (also named CART1) which is an ortholog of mammalian CART Mo et al., 2015) , and it encodes a mature CART peptide of 41 or 48 amino acids, which shows a striking homology (94-98% amino acid identity) with mammalian CART peptide . This suggests CART peptide may play important roles in chickens similar to their mammalian counterparts, such as inhibition of food intake (Tachibana et al., 2003; Honda et al., 2007) . However, unlike mammalian CART abundantly expressed in the hypothalamus and pituitary (Rogge et al., 2008) , chicken CART is predominantly and abundantly expressed in the anterior pituitary . This interesting finding led us to hypothesize that in chickens, CART peptide is a novel pituitary hormone, which expression/secretion is regulated by hypothalamic factors such as CRH demonstrated in our recent study . To further substantiate this hypothesis, using chicken as the animal model, our present study aims to: (1) investigate the effect of other hypothalamic factors, e.g., gonadotropin-releasing hormone (GnRH), on pituitary CART secretion and expression, and the involvement signaling pathways and (2) investigate whether GnRH affects plasma CART levels. Our findings represent the first to establish a clear concept that CART is a pituitary hormone, and its expression, secretion, and plasma levels are under the control of hypothalamic GnRH (GnRH1). Given that GnRH has a pivotal role in the reproduction of vertebrates including birds and mammals (Millar et al., 2004; Millar, 2005) , our findings strongly suggest that CART peptide may also exert some influence on vertebrate reproduction.
MATERIALS AND METHODS

Ethics Statement
Chickens were purchased from local commercial companies. All animal experiments were performed according to the guidelines provided by the Animal Ethics Committee of Sichuan University.
Chemicals, Hormones, Antibodies, and Primers
Chicken GnRH1 and GnRH2 were synthesized using solidphase Fmoc chemistry (GL Biochem, Shanghai, China). The pharmacological agents including 2-aminoethoxydiphenyl borate (2-APB), nifedipine, U73122, thapsigargin, KN62, calmidazolium, phorbol-12-myristate-13-acetate (PMA), calphostin C, PD98059, MDL12330A, and H89 were purchased from Calbiochem (Merck KGaA, Darmstadt, Germany). Rabbit anti-CART polyclonal antibody (CART-H47, sc366086) was purchased from Santa Cruz Biotechnology Inc. (Dallas, TX) and the specificity of anti-CART antibody was validated by Western blot/immunofluorescent detection of CART-specific bands/signals in chicken pituitary (but not in chicken liver, duodenum, and testes, which lack target gene expression) or in HEK293 cells transfected with chicken CART expression plasmid (Cai, MSc thesis 2015) . The monoclonal antibodies for β-actin, phospho-ERK1/2, ERK1/2, and phospho-CREB were purchased from Cell Signaling Technology Inc. (CST, Beverly, MA). Donkey anti-rabbit IgG (H+L) cross adsorbed secondary antibody (Dylight 488 conjugate) was purchased from ThermoFisher Scientific (Waltham, MA). The polyclonal antibodies against recombinant full-length chicken GH and PRL were prepared in our laboratory Meng et al., 2014; Bu et al., 2016) . All primers were synthesized by Beijing Genome Institute (BGI, China) and listed in Chicken anterior pituitaries were collected either for cell culture, or for total RNA extraction. Total RNA was extracted from chicken tissues or cultured pituitary cells using RNAzol (Molecular Research Center, Cincinnati, OH) and reversely transcribed using M-MLV reverse transcriptase (TaKaRa). Reverse transcription (RT) samples were then used for quantitative real-time PCR (qPCR) assays to investigate the mRNA expression of target genes, as described in our recent studies Mo et al., 2015) .
Detection of Cocaine-and AmphetamineRegulated Transcript (CART) Expression in Chicken Pituitaries or Dispersed Pituitary Cells
Anterior pituitaries collected from adult male chickens were fixed in 4% paraformaldehyde and embedded in paraffin wax. Immunohistochemical staining was performed in the pituitary sections, as described in our recent studies Bu et al., 2016) . Anti-CART (1:300) was used to probe the spatial distribution of CART in anterior pituitaries, as previously described . Sections incubated with rabbit pre-immune serum, instead of anti-CART, were used as negative controls. To probe the spatial distribution of pituitary CART mRNA, the anterior pituitaries collected from adult male chickens were washed with PBS. The cephalic lobe and caudal lobe were separated carefully by scalpels, and their respective tissue lysates and total RNA were prepared for qPCR assay of CART (LHβ, GnRHR2, GH, or PRL) expression respectively, as described in our recent studies Mo et al., 2015) .
As described in our recent studies (Bu et al., 2016; Mo et al., 2017) , the dispersed pituitary cells from adult male chickens were cultured in Medium 199 supplemented with 15% fetal bovine serum (Invitrogen) in a Corning Cell-BIND 48-well plates (Corning, Tewksbury, MA) at 37°C with 5% CO 2 at a density of 5 × 10 5 cells/well. After 4 h of culture, the pituitary cells were fixed in 4% paraformaldehyde and washed with PBS. Then, the cells were treated by 0.1% Triton-X-100 for 10 min, washed with PBS, and incubated with the blocking buffer (1% BSA in PBS) for 30 min at room temperature. After blocking, anti-CART (1:300), anti-GH (1:500), or anti-PRL (1:300) diluted in blocking buffer respectively, was added to each well and incubated at 4°C overnight. The cells were washed and incubated with the secondary antibody (1:300) for 1 h at room temperature. Finally, the pituitary cells were counterstained with 1 μg/ml DAPI and observed under a fluorescence microscope (Nikon ECLIPSE Ti). Evaluation of GnRH1/GnRH2 Action on CART Secretion From Intact Pituitaries Incubated in vitro
As described in our recent study , the intact anterior pituitaries collected from 1-week-old male chicks were washed with PBS and placed on a 48-well plate (NUNC) supplemented with 400 μl serum-free Medium 199 (Invitrogen). After 1-h incubation at 37°C, the medium was replaced by 300 μl serum-free Medium 199 containing different concentrations of chicken GnRH1 or GnRH2 (0.1-100 nM) and incubated for 4 h. Then, CART peptide secreted into the incubation medium by the pituitaries was examined by Western blot using anti-CART antibody (1:300). Parallel blotting of β-actin and CART in pituitary tissue lysates was also conducted.
Detection of CART Peptide Levels in Chicken Plasma by Enzyme-Linked Immunosorbent Assay
To evaluate plasma CART peptide levels in chickens, blood samples were obtained from the wing vein of male chickens (2-week-old, 5-month-old, and 15-month-old) and collected in the vacutainer blood collection tubes with K 2 EDTA. All samples were taken from each animal between 14:00 and 15:00. The blood samples were centrifuged at 1,600 × g for 15 min at 4°C, and plasma was collected and stored at −80°C until use. The levels of CART peptide in chicken plasma was determined by a commercially available competitive enzymelinked immunosorbent assay (ELISA) kit (EK-003-61, Phoenix Pharmaceuticals, Inc.), which is designed to specifically detect the CART peptide based on the principle of competitive enzyme immunoassays.
To examine whether GnRH can elevate the plasma CART levels in vivo, male chicks (17-day-old) were intraperitoneally injected with 1 ml of saline for 2 days to acclimatize them to the injection procedure. On the following day, chicks (n = 7/group) were intraperitoneally injected with either saline or 5 μg/chick of GnRH1, and 30 min after the administration, blood was obtained from the wing vein of these chicks and collected in the vacutainer blood collection tubes with K 2 EDTA as soon as possible. The levels of CART Investigation on the Effect of Chicken GnRH1/GnRH2 on CART Expression in Cultured Chick Pituitary Cells As described in our recent studies Mo et al., 2015) , anterior pituitaries collected from 1-week-old chicks were sliced and digested by 0.25% trypsin at 37°C for 20 min. The dispersed pituitary cells were cultured at a density of 5 × 10 5 cells/well in Medium 199 supplemented with 15% fetal bovine serum in a Corning Cell BIND 48-well plates (Corning, Tewksbury, MA) at 37°C with 5% CO 2 . After 24-h culture, the medium was replaced with serum-free M199 medium and the cells were treated with chicken GnRH1/ GnRH2 for the duration (12-48 h) or with increasing doses (0.1-100 nM) of each peptide. The total RNA was then extracted from cultured pituitary cells and the expression of CART and β-actin assayed by qPCR.
Functional Characterization of Chicken GnRHR1 and GnRHR2 in Cultured Chinese Hamster Ovary Cells
Based on the reported cDNA sequences of chicken GnRHR1 and GnRHR2 (accession nos.: NM_204653; NM_001012609) (Sun et al., 2001; Shimizu and Bedecarrats, 2006) , gene-specific primers were used to amplify the open reading frame from adult chicken anterior pituitaries using high-fidelity Taq DNA polymerase (TOYOBO, Japan). The amplified PCR products were cloned into the pcDNA3.1 (+) expression vector (Invitrogen) and sequenced. According to our previously established methods, the signaling property of each receptor was examined in Chinese hamster ovary (CHO) cells using pGL3-NFAT-RE-luciferase (Wang et al., 2012) , pGL4-SREluciferase , and pGL3-CRE-luciferase reporter systems (Wang et al., 2007) .
Data Analysis
The relative mRNA levels of CART (or other genes) in pituitary cells (or pituitary) were first calculated as the ratios to that of β-actin and then expressed as the percentage compared to their respective controls. The data were analyzed by the Student's t-test (between two groups) or by one-way ANOVA followed by the Dunnett test in GraphPad Prism 5 (GraphPad Software, San Diego, CA). To validate our results, all experiments were repeated at least three times.
RESULTS
Detection of Cocaine-and AmphetamineRegulated Transcript (CART) Peptide in Chicken Anterior Pituitary and Plasma
Using immunohistochemical staining (IHC), we first examined the spatial distribution of CART in the anterior pituitary of adult male chicken. As shown in Figure 1A , CART-ir cells were densely distributed in cephalic (Ce) and caudal (Ca) lobes, as previously reported . Using immunofluorescence (IF) assay (Mo et al., 2017) , we further revealed that CART-ir cells made up ~12.3% of the shortterm cultured dispersed pituitary cells (Figures 1B,C) . As a control, somatotrophs (GH cells) and lactotrophs (PRL cells) made up ~12.8 or ~8.5% of the cells under the same condition ( Figure 1C ).
The extremely high expression level of CART and the high proportion of CART-ir cells within the anterior pituitary led us to propose that like GH and PRL, CART can be released into the circulation. As expected, a high concentration (1.2-3.5 ng/ml) of CART was detected in the plasma of male chickens at different developmental stages by ELISA ( Figure 1D ). As shown in Figure 1D , a significant increase in plasma CART levels was noted from the pre-pubertal stage (2-week-old, 1.2 ng/ml) to sexually mature stages (5-month-old, 2.8 ng/ ml; 15-month-old, 3.5 ng/ml). The remarkably high levels of plasma CART, together with the predominant expression of CART in anterior pituitaries, strongly support our hypothesis that CART is a pituitary hormone which is released into the circulation under the control of hypothalamic factors in chickens Mo et al., 2015) .
Gonadotropin-Releasing Hormone (GnRH) Stimulates Pituitary CART Secretion and Elevates Plasma CART Levels
Since the spatial distribution of CART detected by qPCR within anterior pituitaries is much similar to that of LHβ (Proudman et al., 1999; Scanes, 2015) and different from that of GH/PRL (Figure 1E) , it led us to hypothesize that like pituitary LH (Sharp et al., 1986 (Sharp et al., , 1987 , CART secretion is likely controlled by the hypothalamic GnRH in chickens. To test this hypothesis, the effects of two chicken GnRHs (GnRH1 and GnRH2) on CART peptide release were examined both in vitro and in vivo. As shown in Figure 2 , GnRH1 and GnRH2 (0-100 nM, 4 h) potently stimulated the secretion of mature CART peptide with a molecular weight of ~5 kDa (41/48 amino acids) in intact pituitaries incubated in vitro, with the minimal effective concentration observed at 1 nM, as revealed by Western blot. In agreement with this finding, intraperitoneal injection of GnRH1 (5 μg/chick, 30 min) caused a two-fold or higher increase (1.3 vs. 2.7 ng/ml, p < 0.05) in plasma CART levels in vivo, as monitored by ELISA (Figure 3) . These findings clearly indicate that GnRH can potently stimulate pituitary CART secretion and elevate circulating CART levels effectively.
To determine whether the two identified chicken GnRH receptors (GnRHR1 and GnRHR2) are involved in mediating GnRH action on pituitary CART secretion, we examined their expression in the Ce and Ca lobes of chicken anterior pituitaries. GnRHR2 mRNA could easily be detected in both lobes of anterior pituitaries by qPCR (Figure 1E ), while only an extremely weak expression of GnRHR1 mRNA was observed in the anterior pituitary (data not shown). This is similar to a previous report (Joseph et al., 2009) ; hence, it is likely that the action of GnRH on CART secretion is mediated by GnRHR2 predominantly expressed in chicken anterior pituitary.
GnRH Induces CART mRNA Expression in Cultured Chick Pituitary Cells
To further examine whether GnRHs could regulate pituitary CART expression, the effect of GnRH1/2 on CART expression was examined in cultured chick pituitary cells by qPCR. As shown in Figure 4A , GnRH1 could induce CART expression in a time-dependent manner, and the maximal effect was observed after 48-h treatment. Moreover, GnRH1 could stimulate CART expression dose-dependently with the minimal effective dose noted at 1 nM ( Figure 4B ). Like GnRH1, GnRH2 could also induce CART expression in time-and dose-dependent manners (Figures 4C,D) . In agreement with GnRH action on CART expression, GnRH receptor (GnRHR2, not GnRHR1) mRNA could easily be detected in cultured chick pituitary cells by RT-PCR (Figure 4E ), supporting that GnRH-induced CART expression is likely mediated by GnRHR2.
The Action of GnRH on Pituitary CART Expression and Secretion Are Mediated by Multiple Signaling Pathways
Signaling Property of Chicken GnRHR1 and GnRHR2
Although two GnRH receptors (GnRHR1 and GnRHR2) have been identified in chickens (Sun et al., 2001; Shimizu and Bedecarrats, 2006; Joseph et al., 2009) , their downstream signaling pathways have not been fully characterized. Hence, in this study, we first examined the signaling property of chicken GnRHR1 and GnRHR2 using the three cell-based luciferase reporter assays established in our laboratory (pGL3-NFAT-RE-luciferase, pGL4-SRE-luciferase, and pGL3-CREluciferease reporter assay systems) (Wang et al., 2007 (Wang et al., , 2012 Mo et al., 2015) , which are capable of monitoring receptorstimulated calcium, MAPK/ERK, and cAMP/PKA signaling pathways, respectively.
As shown in Figure 5 , using the three cell-based luciferase reporter assays, we found that GnRHR1/GnRHR2 expressed in CHO cells could be activated by chicken GnRH1 and GnRH2, and thus stimulate the luciferase activities dosedependently. This suggests that like mammalian GnRHR (Millar et al., 2004) , both GnRHR1 and GnRHR2 are functionally coupled to the intracellular calcium, MAPK/ERK, and cAMP/ PKA signaling pathways.
Interestingly, we found that GnRHR1 could be potently activated by GnRH2, but not by GnRH1 (Figures 5A-C) , indicating that GnRHR1 is a receptor specific to GnRH2. Unlike GnRHR1, GnRHR2 could be potently activated by both GnRH1 and GnRH2 (with GnRH2 being slightly more potent than GnRH1) (Figures 5D-F) , suggesting that GnRHR2 is a receptor common for both GnRH1 and GnRH2. The EC 50 values of GnRH1 and GnRH2 in activating the two GnRHRs are listed in Table 2 . 
GnRH1-Induced CART Expression and Secretion Are Mediated by Multiple Signaling Pathways
Since GnRHR2 (and GnRHR1) are coupled to multiple signaling pathways (Figure 5) , pharmacological drugs targeting the components of these signaling pathways were used to examine their involvement in mediating the actions of GnRH on pituitary CART expression and secretion.
As shown in Figure 6 , GnRH1-induced CART secretion could be significantly inhibited by U73122 [a phospholipase C (PLC) inhibitor, 20 μM], 2-APB (a specific inhibitor of IP3 receptor, which can block IP3-induced calcium mobilization, 100 μM), and nifedipine (a calcium channel blocker, 5 μM), respectively, in intact pituitaries incubated in vitro, suggesting that GnRH1-induced CART secretion is likely mediated by PLC/IP3/Ca 2+ signaling pathway and calcium channel coupled to GnRHR2. Moreover, we also found that U73122, thapsigargin [an inhibitor of sarco(endo)plasmic reticulum Ca 2+ -ATPase which can deplete intracellular calcium stores, 100 nM], calmidazolium (a calmodulin antagonist, 1 μM), KN62 [a specific inhibitor of Ca 2+ /calmodulin-dependent protein kinase II (CaMKII), 5 μM], and nifedipine (5 μM) could inhibit GnRH1-induced CART mRNA expression in cultured chick pituitary cells (Figures 7A,B) . These findings suggest that PLC/IP3/ Ca 2+ signaling pathway and calcium channel coupled to GnRHR2 could also mediate GnRH1-induced CART mRNA expression.
Interestingly, we also found that calphostin C [a protein-kinase C (PKC) inhibitor, 200 nM] and PD98059 (an MEK inhibitor, 100 μM) could inhibit GnRH1-induced CART mRNA expression in cultured chick pituitary cells, while PMA, a PKC activator (100 nM), could mimic GnRH1 action (Figures 7B,C) . These findings, together with the observation that GnRH1 treatment . (B,C) Western blot analyses showed that (B) chicken GnRH1 (1-100 nM, 4 h) and (B) GnRH2 (0.1-100 nM, 4 h) treatment could enhance the secretion of mature CART peptide into the incubation medium of chick anterior pituitaries incubated in vitro. The intracellular CART (iCART) and β-actin levels in the pituitary tissue lysate were also examined in parallel. The relative CART levels (sCART band, 5 kDa) in the incubation medium were quantified by densitometry, normalized by that of β-actin band in pituitary tissue lysate, and then expressed as fold increase of respective controls without GnRH1/GnRH2 treatment. Each data point represents mean ± SEM of three replicates (N = 3). *p < 0.05; **p < 0.01 vs. respective control. Note: the three major CART bands including the two large CART bands (~10 kDa) and a small band (~5 kDa) were identified in chick pituitary tissue lysate (iCART), whereas only the small band (~5 kDa) representing the mature CART was identified in the incubation medium (sCART) of pituitaries. One representative set of Western blot is shown at the top of each graph.
FIGURE 1 | (D)
Enzyme-linked immunosorbent assay (ELISA) assay of plasma CART peptide levels in male chickens at the stages of 2-week-old (w2), 5-month-old (m5), and 15-month-old (m15). **p < 0.01 vs. w2. Each data point in graphs represents mean ± SEM of four individuals (N = 4). (E) Quantitative real-time PCR (qPCR) assay of CART, LHβ, GnRHR2, GH, and PRL mRNA levels in the Ce and Ca lobes of adult male chicken anterior pituitaries. Each data point represents mean ± SEM of 10 individuals (N = 10). (F) RNA-Seq analyses of CART, GnRHR1, and GnRHR2 mRNA levels in the hypothalamus (Hp) and anterior pituitary (Pi) of 1-week-old male chicks.
(10 nM, 10 min) could enhance ERK2 phosphorylation (42 kDa) in cultured chick pituitary cells (Figure 7D ), suggest the involvement of PKC/MEK/ERK2 signaling cascade in mediating GnRH1-induced CART expression. In addition, we found that forskolin [an adenlyate cyclase (AC) activator, 2 μM] treatment could mimic GnRH1 action on CART expression in cultured chick pituitary cells, while administration of either an AC inhibitor, MDL12330A (20 μM), or a specific PKA inhibitor, H89 (10 μM), could abolish GnRH1-induced CART expression (Figure 8) . These findings, together with the demonstration that GnRH1 (10 nM, 5 min) could enhance CREB phosphorylation (43 kDa) in cultured chick pituitary cells (Figure 8) , suggest that AC/cAMP/PKA/CREB signaling pathway is involved in GnRH1-induced CART expression.
DISCUSSION
In this study, we revealed that a large proportion of CART-ir cells is present in chicken anterior pituitaries, and GnRH stimulates CART secretion and expression in vitro. In addition, CART is present in the plasma at physiological level and GnRH can significantly elevate the circulating CART levels in vivo. To our knowledge, our study provides the first collective evidence that CART is a novel pituitary hormone, and its expression and secretion are controlled by the hypothalamic GnRH in chickens.
Cocaine-and Amphetamine-Regulated Transcript (CART) Is a Pituitary Hormone in Chickens
In our previous study, we found that chicken CART peptide is predominantly and abundantly expressed in the anterior pituitary . In this study, using IHC and IF, we further demonstrated that CART-ir cells are densely distributed throughout the anterior pituitary and they made up ~12.3% of pituitary cells, which is comparable to the percentage of the other two hormone-producing cells (GH cells: ~12.8%; PRL cells: ~8.5%) (Figure 1 ; Mo et al., 2017 ). The extremely high expression level of CART in chicken anterior pituitaries is substantiated by our transcriptome analysis, in which CART is shown to be predominantly expressed in chick anterior pituitary, but not in the hypothalamus ( Figure 1F ). All these findings suggest that CART is a novel pituitary hormone in chickens. Similarly, CART mRNA and protein has been reported to be localized in the anterior pituitary in mammals Murphy et al., 2000) . In rodents, CART-ir signals are localized in several hormone-producing cells, including gonadotrophs, lactotrophs, and corticotrophs (Kuriyama et al., 2004; Stanley et al., 2004; Kappeler et al., 2006; Smith et al., 2006) . Consistent with the findings in chickens and mammals, CART mRNA is reported to be expressed in goldfish pituitaries (Volkoff and Peter, 2001) . Taken together, this suggests that CART may act as a pituitary hormone involved in the regulation of many physiological processes in birds and mammals, and possibly across other vertebrates as well.
In agreement with the idea that CART is a pituitary hormone in chickens, a remarkably high concentration of plasma CART peptide (1.2-3.5 ng/ml ≈ 0.2-0.7 nM) was detected in chickens at pre-pubertal and sexually mature stages, with the concentration peak noted at the latter sexually mature stage (Figure 1) . Since CART is predominantly expressed in the anterior pituitary (Figure 1 ), the high circulating CART level is most likely contributed by this tissue. This is consistent with the findings in mammals, in which a high concentration of plasma CART peptide is present (~0.05-0.25 ng/ml in rats; 0.075-0.125 ng/ml in monkeys; 0.15-0.44 nM in humans) (Stanley et al., 2004; Vicentic et al., 2004; Kappeler et al., 2006; Bech et al., 2008) and contributed mainly by the anterior pituitary and secondarily by other peripheral tissues (e.g., ovary, gut, and fat) (Stanley et al., 2004) .
The identification of CART peptide as a pituitary hormone in chickens, together with the evidence on gastrin-releasing peptide (GRP) being a potential pituitary hormone presented in our recent study (Mo et al., 2017) , undoubtedly stresses the importance on revisiting the basic concept of avian pituitary biology, i.e., the avian anterior pituitary, which has long been thought to produce six classic hormones (GH, PRL, ACTH, TSH, FSH, and LH) (Proudman et al., 1999; Scanes, 2015) , secretes additional endocrine hormones including CART and GRP peptides. 
GnRH1 Stimulates CART Secretion and Expression: Implications for the Roles of CART in Vertebrate Reproduction
In this study, we found that CART-ir cells have a spatial distribution similar to that of gonadotropins (e.g., LH), which are distributed throughout both cephalic and caudal lobes (Figure 1 ; Proudman et al., 1999; Scanes, 2015) . This points to the possibility that like LH (Chou et al., 1985; Hattori et al., 1986; Sharp et al., 1986) , CART secretion and expression may be controlled by hypothalamic GnRH. In agreement with this idea, we found that GnRH can potently stimulate CART secretion and expression in vitro (Figures 2, 4) , and elevate the plasma CART levels in vivo (Figure 3) . Our findings clearly indicate that besides hypothalamic CRH , GnRH is another potent stimulator of pituitary CART secretion and expression in chickens. Considering that the mRNA expression and pulsatile secretion of hypothalamic GnRH is reported to be negatively regulated by CRH in mammals (Kageyama, 2013) , it is likely that in chickens, hypothalamic GnRH and CRH may regulate pituitary CART expression and secretion in a coordinated manner in vivo; however, this hypothesis still requires further elucidation. It is reported that CART peptide is co-localized with FSH and LH in rat gonadotrophs (Kuriyama et al., 2004; Kappeler et al., 2006) . Although GnRH-induced pituitary CART expression has not been reported in any other vertebrate species before, a previous study suggested that CART secretion is induced from rat pituitary upon perfusion with GnRH (Kappeler et al., 2006) . Hence, it is tempting to hypothesize that hypothalamic GnRH may play a conserved role in the control of pituitary CART expression and secretion, and the subsequent circulating CART level in birds and mammals ( Figure 9A) . Nevertheless, this theory has yet been substantiated in mammals.
There has so far been a research gap regarding the role of circulating CART peptide in birds and mammals. In this study, we noted that plasma CART levels are significantly
FIGURE 5 | Activation of chicken GnRHR1 or GnRHR2 expressed in CHO cells by chicken GnRH1 or GnRH2, monitored by pGL3-NFAT-RE-luciferase (A,D), pGL4-SRE-luciferase (B,E), and pGL3-CRE-luciferease (C,F) reporter systems. CHO cells co-transfected with empty pcDNA3.1(+) vector and pGL3-NFAT-REluciferase (/pGL4-SRE-luciferase or pGL3-CRE-luciferease) reporter construct were used as internal controls, and peptide treatment did not alter the luciferase activity of CHO cells at any concentration tested (data not shown). Each data point represents mean ± SEM of four replicates (N = 4). higher in sexually mature chickens than in immature chicks ( Figure 1D ). This is in line with the highest mRNA level of CART detected in the anterior pituitary of sexually mature chickens in our recent study . Moreover, we demonstrated that GnRH can rapidly elevate plasma CART levels (Figure 3) . Considering that GnRH is a pivotal player in the reproduction of birds and other vertebrate groups including the teleosts, frogs, reptiles, and mammals (Millar, 2005) , it led us to speculate that circulating CART is likely involved in the control of reproduction, such as regulation of the development and/or functions of gonads (testis/ovary) via yet-to-be identified CART receptor(s) ( Figure 9A ; Sen et al., 2007; Rogge et al., 2008) . In mammals, there has been emerging evidence showing that CART may play a role in reproduction. In rodents, CART has been demonstrated to be a potent stimulator of both GnRH and kisspeptin (an up-regulator of GnRH neuron) neurons within the hypothalamus. CART-ir fibers are in close contact with GnRH cells and kisspeptin cells in rats, and this proximity may enhance both the amplitude and frequency of pulsatile GnRH secretion directly and indirectly (Lebrethon et al., 2000; de Roux et al., 2003; Irwig et al., 2004; True et al., 2013; Verma et al., 2014) . In cows and ewes, CART is reported to be expressed in the ovary and present in ovarian follicular fluid (Kobayashi et al., 2004; Juengel et al., 2017) . Moreover, in vitro experiments further supported that CART can inhibit basal and FSH-induced estradiol production in granulosa cells and may act as an important local autocrine/paracrine factor involved in the regulation of ovarian follicle development and steroidogenesis (Sen et al., 2007; Ma et al., 2016; Juengel et al., 2017) . These pioneering findings, together with our convincing evidence showing that the expression and secretion of CART in chicken pituitary is regulated by GnRH (Figures 2-4) , suggest that CART can act at different tier(s) of the hypothalamic-pituitary-gonadal axis (HPG) to regulate vertebrate reproduction (Kobayashi et al., 2004; True et al., 2013; Juengel et al., 2017) .
GnRH1-Induced CART Expression Is Mediated by Multiple Signaling Pathways Coupled to GnRHR2
In this study, we found that GnRHR2 is abundantly expressed in chicken anterior pituitaries, whereas GnRHR1 is almost undetectable. Our finding agrees with our transcriptome analysis showing the predominant expression of GnRHR2 (not GnRHR1) in chick anterior pituitary ( Figure 1F ) and a recent observation that GnRHR2 is abundantly expressed in chicken pituitaries (Joseph et al., 2009) . All these findings indicate that GnRH1-induced CART secretion and expression is primarily mediated by GnRHR2 (and not GnRHR1) expressed in chicken anterior pituitaries ( Figure 9A) . Meanwhile, the potent effect of GnRH on CART secretion, together with the similar spatial distribution patterns of CART, GnRHR2, and LHβ within anterior pituitaries (Figure 1E) , also suggests that CART peptide is likely localized in gonadotrophs (e.g., LH cells) expressing GnRH receptor (Figure 9) , as in mammals (Kuriyama et al., 2004; Kappeler et al., 2006) .
To elucidate the downstream signaling pathways coupled to GnRHR2 (and GnRHR1), using the three established cell-based luciferase reporter assays, we further examined the signaling properties of the two GnRH receptors. We demonstrated that like mammalian GnRHR (Millar et al., 2004) , chicken GnRHR2 (and GnRHR1) expressed in CHO cells is functionally coupled to the calcium, MAPK/ERK, and cAMP/PKA signaling pathways (Figure 5) . Our finding partially agrees with previous studies, in which activation of chicken GnRHR2 (and GnRHR1) expressed in COS-7 cells or GH3 cells can increase intracellular IP3 levels and may stimulate the cAMP/PKA signaling pathway Bedecarrats, 2006, 2010; Joseph et al., 2009) . Considering that chicken GnRH1 (an ortholog of mammalian GnRH), and not GnRH2, is present in the median eminence and directly involved in the control of LH secretion via GnRHR2 expressed in the chicken anterior FIGURE 6 | Western blot detected the effect of chicken GnRH1 (5 nM, 4 h) on cocaine-and amphetamine-regulated transcript (CART) secretion in the incubation medium of chick pituitaries incubated in vitro in the presence of 2-APB (100 μM), nifedipine (NIF, 5 μM), or U73122 (U7, 20 μM). The relative CART levels (sCART: ~5 kDa band) in the incubation medium were quantified by densitometry, normalized by that of β-actin band in pituitary tissue lysate, and then expressed as fold increase of controls without any treatment. iCART, intracellular CART, showed three major bands in pituitary tissue lysates. Each data point represents mean ± SEM of three replicates (N = 3).
# p < 0.001 vs. control; *p < 0.05, **p < 0.01 vs. GnRH1 treatment (in the absence of drug). One representative set of Western blotting is shown at the bottom.
pituitary (Sharp et al., 1990; Joseph et al., 2009) , the high potency of GnRH1 in activating GnRHR2 ( Table 2 ) also hints of the potential physiological importance of GnRH1-GnRHR2 signaling in the regulation of gonadotropin secretion and reproduction in chickens (Sharp et al., 1990; Joseph et al., 2009 , PKC/MEK/ERK2, and AC/cAMP/ PKA/CREB signaling pathways coupled to GnRHR2 could mediate GnRH1-induced CART expression and secretion, since inhibition or activation of these signaling pathways could block or mimic the GnRH1 action ( Figure 9B ). Our findings partially agree with the previous reports in mammals, in which the Ca 2+ signaling pathway has been shown to regulate CART expression in pituitary cells or non-pituitary cells, via the use of pharmacological drugs including ionomycin and inhibitors of calmodulin and CaMKII (Jones et al., 2009) . Moreover, PMA, a PKC activator, enhances CART mRNA expression in ovine pars tuberalis cells (Barrett et al., 2001 ). In addition, the CART mRNA levels are enhanced by an AC activator or a cAMP analog, and their stimulatory effect is abolished by H89 in rat GH3 cells (Barrett et al., 2001) . Western blot showed that GnRH1 treatment (10 nM, 10 min) could enhance ERK2 phosphorylation (pERK2) in cultured chick pituitary cells. Total ERK2 in cell lysates was also examined and used as internal controls. Note: only a single band for pERK2 or total ERK2 (42 kDa) was detected in cell lysate, because ERK1 gene is lost in chicken genome (Gerilechaogetu et al., 2009 ). The representative sets of independent experimental duplicates are shown here.
All these findings support the involvement of intracellular PKC and AC/cAMP/PKA signaling pathways in the regulation of CART expression in birds and mammals.
In summary, we demonstrated that GnRH can potently stimulate pituitary CART secretion and expression, an action mediated by GnRHR2 coupled to Ca 
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FIGURE 9 | (A) Hypothetic model for gonadotropin-releasing hormone (GnRH)-induced pituitary cocaine-and amphetamine-regulated transcript (CART) expression and secretion, which may act on chicken gonads (ovaries/testes) via an endocrine route. In this model, CART is a novel pituitary hormone, and its secretion into the circulation is potently stimulated by hypothalamic GnRH1 (an ortholog of mammalian GnRH), suggesting that the development and functions of gonads (ovaries/testes) are likely controlled by CART peptide secreted from the anterior pituitary via CART receptor(s), which has not been identified in vertebrates.
(B) The signaling pathways involved in mediating GnRH1-induced CART expression and secretion in pituitary gonadotrophs. In this model, GnRH1 stimulates CART expression and/or secretion via activation of GnRHR2 coupled to calcium channel and multiple signaling pathways including Gq-PLC/IP3/Ca 2+ , PKC/MEK/ERK, and Gs-AC/PKA/cAMP signaling pathways.
cAMP/PKA signaling pathways (Figure 9 ). In line with this finding, GnRH1 can also elevate the plasma CART levels in vivo. To our knowledge, our study represents the first to build a clear concept that CART is a novel pituitary hormone and its expression, secretion, and plasma level are tightly controlled by hypothalamic GnRH in chickens. Evidence presented here also implies that CART peptide may play an active role in the HPG axis of vertebrate, which is a new facet of research that has long been neglected and is worthwhile exploring.
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